14 studies found for:    epilepsy Michigan | Open Studies
Show Display Options
RSS Create an RSS feed from your search for:
epilepsy Michigan | Open Studies
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting The Human Epilepsy Project
Condition: Focal Epilepsy
Intervention:
2 Recruiting Study to Evaluate the Safety and Efficacy of USL261 (Intranasal Midazolam) in Patients With Seizure Clusters
Condition: Epilepsy
Interventions: Drug: USL261;   Drug: Placebo
3 Recruiting A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures
Condition: Tuberous Sclerosis Complex-associated Refractory Seizures
Interventions: Drug: RAD001;   Drug: Placebo
4 Recruiting Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
Condition: Epilepsy
Intervention: Drug: USL261
5 Unknown  Seizure Prophylaxis in Aneurysm Repair
Conditions: Intracranial Aneurysms;   Seizure
Intervention: Drug: Levetiracetam
6 Recruiting Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo
Condition: Epilepsies, Partial
Interventions: Drug: Lyrica (pregabalin);   Drug: placebo
7 Recruiting Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Conditions: Epilepsy;   Pregnancy
Intervention:
8 Recruiting A Study to Investigate the Safety of the Drugs Topiramate and Levetiracetam in Treating Children Recently Diagnosed With Epilepsy
Condition: Epilepsy
Interventions: Drug: Topiramate;   Drug: Levetiracetam
9 Recruiting Study to Evaluate the Safety and Efficacy of USL261 in Patients With Increased Bouts of Seizure Activity in the EMU
Condition: Epilepsy
Interventions: Drug: USL261;   Drug: Placebo
10 Recruiting Study to Evaluate SAGE-547 Injection as Adjunctive Therapy for the Treatment of Super-Refractory Status Epilepticus
Condition: Super-refractory Status Epilepticus
Intervention: Drug: SAGE-547
11 Recruiting An Open Label Study to Evaluate the Effects of Ezogabine/Retigabine Added to Existing Anti-epileptic Drug(s) on Urinary Voiding Function in Subjects With Partial Onset Seizures
Condition: Epilepsy
Intervention: Drug: ezogabine/retigabine
12 Recruiting Evaluation of Neuroinflammation in Children With Infantile Spasms
Condition: Infantile Spasms
Intervention: Drug: ACTH
13 Not yet recruiting Established Status Epilepticus Treatment Trial
Condition: Benzodiazipine Refractory Status Epilepticus
Interventions: Drug: Fosphenytoin;   Drug: Levetiracetam;   Drug: Valproic acid
14 Recruiting Transfusion of Prematures Trial
Conditions: Infant, Newborn, Diseases;   Infant, Extremely Low Birth Weight;   Infant, Small for Gestational Age;   Bronchopulmonary Dysplasia (BPD);   Anemia
Interventions: Procedure: Liberal Cell Transfusion;   Procedure: Restricted red cell transfusion

Indicates status has not been verified in more than two years